title: Recurrent angioedema associated with efalizumab.
authors.forename: Lotus
authors.initials: L
authors.lastname: Mallbris
authors.forename: Fredrik
authors.initials: F
authors.lastname: von Bergen
authors.forename: Marianne
authors.initials: M
authors.lastname: van Hage
authors.forename: Mona
authors.initials: M
authors.lastname: Ståhle
mesh_terms: D000799:Angioedema / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D012008:Recurrence
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab